What is the appropriate treatment for Enterococcus faecalis colonization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Enterococcus faecalis Colonization Does Not Require Treatment

Colonization with Enterococcus faecalis should not be treated with antibiotics. The critical distinction between colonization and true infection must be made before any antimicrobial therapy is initiated 1.

Key Principle: Colonization vs. Infection

The guidelines explicitly emphasize that "it is important to differentiate colonization from true infection prior to empiric prescription of anti-VRE antimicrobial agents" 1. This principle applies equally to vancomycin-susceptible E. faecalis.

When NOT to Treat (Colonization):

  • Positive cultures from surveillance specimens (rectal swabs, stool cultures) without clinical infection 2
  • Asymptomatic bacteriuria in non-pregnant patients without urinary symptoms
  • Wound colonization without signs of active infection
  • Respiratory colonization without pneumonia

When TO Treat (True Infection):

Treatment is indicated only when E. faecalis causes documented infection with clinical signs and symptoms:

For Urinary Tract Infections:

  • Ampicillin remains the drug of choice for enterococcal infections 1
  • High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg IV/PO every 8 hours for uncomplicated UTI 1
  • Alternative: Fosfomycin 3 g PO single dose for uncomplicated UTI 1
  • Alternative: Nitrofurantoin 100 mg PO every 6 hours 1

For Bloodstream Infections:

  • Linezolid 600 mg IV or PO every 12 hours (strong recommendation) 1
  • High-dose daptomycin 8-12 mg/kg IV daily, potentially combined with β-lactams 1

For Intra-abdominal Infections:

  • Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours 1
  • Ampicillin 2 g every 6 hours in combination regimens 3, 4

For Endocarditis:

  • Ampicillin 200 mg/kg/day IV in 4-6 doses plus gentamicin 3 mg/kg/day for 2-6 weeks 5
  • Alternative: Ampicillin plus ceftriaxone 4 g/day for 6 weeks 5, 6

Critical Pitfalls to Avoid

  1. Do not treat positive surveillance cultures: Screening cultures from stool or rectal swabs identify colonization, not infection 2

  2. Avoid unnecessary broad-spectrum antibiotics: Inappropriate antimicrobial use drives resistance emergence 1

  3. Do not use ineffective agents: Metronidazole, clindamycin, and cephalosporins (except in specific combinations) have poor activity against enterococci 3, 7

  4. Recognize high-risk situations requiring anti-enterococcal coverage (these are infections, not colonization):

    • Healthcare-associated intra-abdominal infections
    • Post-operative infections
    • Immunocompromised patients
    • Patients with valvular heart disease or prosthetic materials 3

Infection Control for Colonized Patients

For patients colonized with E. faecalis (particularly vancomycin-resistant strains), focus on infection prevention rather than antimicrobial treatment:

  • Contact precautions for VRE-colonized patients
  • Hand hygiene compliance
  • Environmental cleaning
  • Removal of unnecessary catheters and devices 1, 2

The evidence consistently demonstrates that treating colonization does not improve outcomes and contributes to antimicrobial resistance. Treatment should be reserved exclusively for documented infections with clinical manifestations requiring therapy.

Related Questions

What is the optimal antibiotic therapy for Enterococcus faecalis infection?
What is the recommended treatment for an Enterococcus faecalis wound infection in an adult without a β‑lactam allergy?
What are the current treatment guidelines for Enterococcus faecalis bacteremia?
In an elderly patient with recent Enterococcus faecalis urinary tract infection, bacteremia, and endocarditis, a 4 mm aortic bioprosthetic valve opacity, now presenting with painful palpable purpura that has progressed to bullae and new transaminitis while on daptomycin, who previously received intravenous ampicillin and ceftriaxone (Rocephin) and has a history of transcatheter aortic valve replacement (TAVR) with pacemaker, atrial fibrillation on apixaban (Eliquis), and daily furosemide with as‑needed potassium supplementation, how should I work up and manage the suspected drug‑induced bullous leukocytoclastic vasculitis versus other vasculitic etiologies from a pharmacy standpoint?
What empiric antibiotic regimen should be used for culture-negative infective endocarditis in a patient with an ampicillin allergy?
How does ABVD chemotherapy (doxorubicin, bleomycin, vincristine, dacarbazine) for Hodgkin lymphoma cause bilateral upper extremity peripheral neuropathy with distal fingertip numbness, reduced grip strength, and loss of temperature sensation?
Can pseudoephedrine (Sudafed) be safely combined with another over‑the‑counter cold medication for sore‑throat pain?
What is the recommended management of pulmonary embolism causing cardiac arrest?
What infection control precautions are recommended for a patient colonized with Enterococcus faecalis, including vancomycin‑resistant strains?
Interpret this arterial blood gas (ABG) with pH 7.40, PaCO₂ 38 mm Hg, PaO₂ 372 mm Hg, and HCO₃⁻ 24.1 mmol/L.
What are the long-term risks of testosterone therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.